These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35806049)
1. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[ Tsai CJ; Chiu CH; Kuo YY; Huang WS; Yu TH; Flores LG; Yeh SH; Ma KH Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806049 [TBL] [Abstract][Full Text] [Related]
2. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Li IH; Huang WS; Shiue CY; Huang YY; Liu RS; Chyueh SC; Hu SH; Liao MH; Shen LH; Liu JC; Ma KH Neuroimage; 2010 Jan; 49(2):1259-70. PubMed ID: 19682588 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study. Shih JH; Ma KH; Chen CF; Cheng CY; Pao LH; Weng SJ; Huang YS; Shiue CY; Yeh MK; Li IH Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383 [TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals. Chiu CH; Ma KH; Huang EY; Chang HW; Weng SJ; Yu TH; Farn SS; Kuo YY; Huang WS; Cheng CY; Tao PL; Yeh SH J Chin Med Assoc; 2024 May; 87(5):538-549. PubMed ID: 38587377 [TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575 [TBL] [Abstract][Full Text] [Related]
6. Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[ Yeh SH; Kuo YY; Huang WS; Chiu CH; Yu TH; Ii LGF; Tsai CJ; Cheng CY; Ma KH Front Neurosci; 2022; 16():837194. PubMed ID: 35692422 [TBL] [Abstract][Full Text] [Related]
7. Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study. Chen YA; Huang WS; Lin YS; Cheng CY; Liu RS; Wang SJ; Li IH; Huang SY; Shiue CY; Chen CY; Ma KH Nucl Med Biol; 2012 Feb; 39(2):279-85. PubMed ID: 22136885 [TBL] [Abstract][Full Text] [Related]
8. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity. Li IH; Ma KH; Kao TJ; Lin YY; Weng SJ; Yen TY; Chen LC; Huang YS Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922 [TBL] [Abstract][Full Text] [Related]
9. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats. Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457 [TBL] [Abstract][Full Text] [Related]
10. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106 [TBL] [Abstract][Full Text] [Related]
11. Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET. Kang HH; Wang CH; Chen HC; Li IH; Cheng CY; Liu RS; Huang WS; Shiue CY; Ma KH Neuroimage; 2013 Jul; 75():262-269. PubMed ID: 22766166 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256 [TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4-methylenedioxymethamphetamine users. van de Blaak FL; Dumont GJH Hum Psychopharmacol; 2022 Jan; 37(1):e2811. PubMed ID: 34506649 [TBL] [Abstract][Full Text] [Related]
14. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Vegting Y; Reneman L; Booij J Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200 [TBL] [Abstract][Full Text] [Related]